| Literature DB >> 16219583 |
Cees G Schaar, Henricus J Vermeer, Pierre W Wijermans, Wim Huisman, Saskia le Cessie, Hanneke C Kluin-Nelemans.
Abstract
Serum syndecan-1 was investigated in 189 patients with newly diagnosed monoclonal proteinemia [the diagnoses were multiple myeloma (66), monoclonal gammopathies of undetermined significance (MGUS; n=54), provisional MGUS (no bone marrow examination performed; n=69)] and 36 controls. Syndecan-1 levels ranged widely between all diagnostic categories and were of limited discriminatory value (sensitivity 68%, specificity 78%) in patients with newly diagnosed monoclonal proteinemia.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16219583
Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941